Home / Stocks / CNTA

CNTA insider trading

Centessa Pharmaceuticals plc — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
1
Bought · 24 mo
$5.9M
Buys · last 90 days
0 · $0
Most recent buy
2025-05-19

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-27Anderson Karen M.
Chief People Officer
Sold41,076$30.12$1.2M
2026-03-18Anderson Karen M.
Chief People Officer
Sold64,768$28.21$1.8M
2026-03-16Anderson Karen M.
Chief People Officer
Sold107,961$26.15$2.8M
2026-03-13Anderson Karen M.
Chief People Officer
Sold107,961$26.15$2.8M
2026-03-13Weinhoff Gregory M
Chief Business Officer
Sold61,253$26.17$1.6M
2025-11-18Bush Tia L
Chief Technology & Quality Ofc
Sold40,000$28.00$1.1M
2025-11-13Bush Tia L
Chief Technology & Quality Ofc
Sold40,000$26.00$1.0M
2025-05-19GOYAL ARJUN
Director
Bought462,585$12.68$5.9M
2024-12-17HUSSAIN IQBAL J
General Counsel
Sold77,705$16.39$1.3M
2024-12-06SAHA SAURABH
Chief Executive Officer
Sold87,496$18.46$1.6M
2024-09-12SAHA SAURABH
Chief Executive Officer
Sold175,000$16.52$2.9M

Most active insider buyers

InsiderRoleBuysTotal bought
GOYAL ARJUNDirector1$5.9M

See CNTA on the chart

Every insider buy and sell for CNTA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.